Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Framework for Tocilizumab - March 2024

NHS England

This public procurement record has 2 releases in its history.

Award

08 Apr 2024 at 17:44

Award Notice
Tender

29 Nov 2023 at 14:39

Tender Notice
Summary of the contracting process

The NHS England has completed the procurement process for the NHS National Framework for Tocilizumab - March 2024. This tender falls under the goods category and involves pharmaceutical products. The framework covers two regions: LONDON and SOUTH OF ENGLAND, and NORTH OF ENGLAND and MIDLANDS AND EAST, with an initial period from 1 March 2024 to 28 February 2025, extendable up to 24 months. The procurement method used was the open procedure, and the authority for this tender is NHS England. The award was granted to Roche Products Ltd and Fresenius Kabi Limited.

This tender for the NHS National Framework for Tocilizumab presents a lucrative opportunity for businesses operating in the pharmaceutical industry. Companies specialising in the production and supply of pharmaceutical products, particularly in the specified regions, would be well-suited to compete for potential contract extensions. By engaging in this procurement process, businesses can establish long-term partnerships with NHS England and contribute to the provision of healthcare services to the identified regions.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework for Tocilizumab - March 2024

Notice Description

Project Title: NHS National Framework for Tocilizumab - March 2024<br/> <br/>Offer reference number: CM/PHR/23/5702<br/><br/>CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. <br/><br/>CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Lot Information

CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND.

CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Options: There will be an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AN

CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Options: There will be an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-041db8
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/011334-2024
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£150,000,000 £100M-£1B
Lots Value
£150,000,000 £100M-£1B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
8 Apr 20242 years ago
Submission Deadline
3 Jan 2024Expired
Future Notice Date
Not specified
Award Date
11 Mar 20242 years ago
Contract Period
1 Mar 2024 - 28 Feb 2025 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS1 4AP
Postcode Area
Leeds
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified
Local Authority
Leeds
Electoral Ward
Hunslet & Riverside
Westminster Constituency
Leeds South

Supplier Information

Number of Suppliers
2
Supplier Names

Fresenius Kabi Limited

Roche Products Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...